Drug Transporter-Mediated Protection of Cancer Stem Cells From Ionophore Antibiotics

The side population of ovarian cancer cells defines a heterogeneous compartment exhibiting stem cell characteristics

(2015) Maximilian Boesch et al.   Oncotarget

Tackling the cancer stem cells — what challenges do they pose?

(2014) Diwakar R. Pattabiraman et al.   NATURE REVIEWS DRUG DISCOVERY

Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance

(2013) Wen Yue et al.   Autophagy

The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells

(2013) Soshi Kusunoki et al.   GYNECOLOGIC ONCOLOGY

Salinomycin induces cell death and differentiation in head and neck squamous cell carcinoma stem cells despite activation of epithelial-mesenchymal transition and Akt

(2012) Selena Z Kuo et al.   BMC CANCER

Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress

(2012) K Ketola et al.   BRITISH JOURNAL OF CANCER

DyeCycle violet used for side population detection is a substrate of P-glycoprotein

(2012) Maximilian Boesch et al.   CYTOMETRY PART A

DNA Damage Repair Pathways in Cancer Stem Cells

(2012) M. Maugeri-Sacca et al.   MOLECULAR CANCER THERAPEUTICS

Salinomycin inhibits osteosarcoma by targeting its tumor stem cells

(2011) Qing-Lian Tang et al.   CANCER LETTERS

Ovarian Cancer Stem Cell-Like Side Populations Are Enriched Following Chemotherapy and Overexpress EZH2

(2011) S. Rizzo et al.   MOLECULAR CANCER THERAPEUTICS

Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells

(2011) Desheng Lu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells

(2010) Dominik Fuchs et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor

(2010) Roberta Riccioni et al.   BLOOD CELLS MOLECULES AND DISEASES

Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant

(2010) L Hu et al.   BRITISH JOURNAL OF CANCER

Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells

(2009) Dominik Fuchs et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening

(2009) Piyush B. Gupta et al.   CELL

The Side Population of Ovarian Cancer Cells Is a Primary Target of IFN-  Antitumor Effects

(2008) L. Moserle et al.   CANCER RESEARCH